Navigation Links
Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership
Date:7/20/2010

NORTH ATTLEBORO, Mass., July 20 /PRNewswire/ -- Medical Device Consultants, Inc. (MDCI), a full-service regulatory consulting and contract research organization (CRO) serving the medical device and diagnostics industry, today announced a strategic partnership with Clinical Development & Support Services Ltd (CDSS), a clinical services and CRO based in Cheshire, England.  This relationship will allow clients access to the best of both organizations' core strengths and geographical expertise.  The service expansion will be accomplished through mutual referrals, coordinated sales, marketing, and presentation activities.

Leslie Rose, Director of Clinical Services at MDCI said, "Our primary aim is to fully support clients as they design and conduct medical device and IVD clinical trials both in the US and Europe. The CDSS network of employee and contract clinical research professionals in the UK and across Europe complements MDCI's full service CRO activities.  This collaboration of two former competitors combines our strengths to provide broader and deeper clinical and regulatory solutions for all of our medical device clients."

John Illingworth, Manager Director at CDSS said, "We recognize that our clients need to ensure their clinical research plans meet International regulatory requirements especially in the US and Europe.  MDCI's extensive regulatory expertise and network of clinical research professionals in the US makes our alliance a perfect match to achieve this.  The blend of both CDSS' and MDCI's skills and infrastructure will allow us to provide all the benefits of working with a large, multinational CRO, whilst retaining the personal, tailored service that both companies pride themselves on."

About MDCI

MDCI is a full-service regulatory consulting firm and contract research organization (CRO) that helps emerging and established firms commercialize novel and innovative medical devices, in vitro diagnostics, and combination products.  Clients trust MDCI to deliver customized strategic guidance and creative "hands-on" solutions to address their unique regulatory, clinical trial, and quality assurance challenges at every stage of the product lifecycle.  MDCI has helped hundreds of clients conduct successful clinical trials, achieve regulatory clearance and approval, and maintain compliance for products in the U.S. and internationally.  By leveraging MDCI's comprehensive knowledge of FDA and international regulations, clients capture and grow market share, increase productivity, and stay competitive in an increasingly complex global marketplace.  MDCI has offices in Massachusetts and California.  Additional information is available at www.mdci.com.

About CDSS

CDSS has over 30 years experience in providing a wide range of clinical development services to medical device, pharmaceutical and biotechnology companies within the healthcare industry, specialising in Phase I to Phase IV clinical trials and in the provision of monitoring and contract research nursing services.  CDSS is the UK's leading independent research nurse provider.  Having worked with clients in the UK, Europe and the US, ranging from small start-up companies to large multinational corporations and the National Health Service (NHS), CDSS recognises the individual requirements of clients and provides a service tailored to individual needs.  By working closely with the British Consulate across the US, CDSS can help to provide information on and access to any R&D grants, funding or tax credits, which may be available.  CDSS has offices in the North of England and Massachusetts, USA.   Additional information is available at www.cdssltd.com.


'/>"/>
SOURCE Medical Device Consultants, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... Grothey ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... http://photos.prnewswire.com/prnh/20151014/276718LOGO) Published recently in ... the peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... bible in homes across the world. Yisrayl says this generation is a time like no ... to turn to the Bible. , Yisrayl says he does not want to sound like ...
(Date:1/20/2017)... ... January 20, 2017 , ... Doctor C LLC, a company ... January ECRM trade show to continue the marketing and distribution of its product, The ... for providing 400 percent better absorption than traditional vitamin C supplements. At the trade ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Lice Troopers, ... lice cases in families with school-aged children since the holiday season. , “It ... holidays with their families, sharing hugs and taking photos, which is the head-to-head gateway ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... International ... of nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in ... bodybuilder and nutritional scientist who was determined to create a line of products that ...
(Date:1/20/2017)... California (PRWEB) , ... January 20, 2017 , ... "TransFlare ... to use inside of Final Cut Pro X," said Christina Austin - CEO of ... the RED Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak ...
Breaking Medicine News(10 mins):